Gut microbiota and atherosclerosis: role of B cell for atherosclerosis focusing on the gut-immune-B2 cell axis
- PMID: 32737524
- PMCID: PMC7447622
- DOI: 10.1007/s00109-020-01936-5
Gut microbiota and atherosclerosis: role of B cell for atherosclerosis focusing on the gut-immune-B2 cell axis
Abstract
Atherosclerosis is the leading cause of cardiovascular mortality and morbidity worldwide and is described as a complex disease involving several different cell types and their molecular products. Recent studies have revealed that atherosclerosis arises from a systemic inflammatory process, including the accumulation and activities of various immune cells. However, the immune system is a complicated network made up of many cell types, hundreds of bioactive cytokines, and millions of different antigens, making it challenging to readily define the associated mechanism of atherosclerosis. Nevertheless, we previously reported a potential persistent inflammatory process underlying atherosclerosis development, centered on a pathological humoral immune response between commensal microbes and activated subpopulations of substantial B cells in the vicinity of the arterial adventitia. Accumulating evidence has indicated the importance of gut microbiota in atherosclerosis development. Commensal microbiota are considered important regulators of immunity and metabolism and also to be possible antigenic sources for atherosclerosis development. However, the interplay between gut microbiota and metabolism with regard to the modulation of atherosclerosis-associated immune responses remains poorly understood. Here, we review the mechanisms by which the gut microbiota may influence atherogenesis, with particular focus on humoral immunity and B cells, especially the gut-immune-B2 cell axis. Graphical abstract Under high-fat and high-calorie conditions, signals driven by the intestinal microbiota via the TLR signaling pathway cause B2 cells in the spleen to become functionally active and activated B2 cells then modify responses such as antibody production (generation of active antibodies IgG and IgG3), thereby contributing to the development of atherosclerosis. On the other hand, intestinal microbiota also resulted in recruitment and ectopic activation of B2 cells via the TLR signaling pathway in perivascular adipose tissue (PVAT), and, subsequently, an increase in circulating IgG and IgG3 led to the enhanced disease development. This is a potential link between microbiota alterations and B cells in the context of atherosclerosis.
Keywords: Atherosclerosis; B2 cells; Commensal microbiota; Inflammation.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Commensal Microbe-specific Activation of B2 Cell Subsets Contributes to Atherosclerosis Development Independently of Lipid Metabolism.EBioMedicine. 2016 Nov;13:237-247. doi: 10.1016/j.ebiom.2016.10.030. Epub 2016 Oct 20. EBioMedicine. 2016. PMID: 27810309 Free PMC article.
-
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014. Microbiol Spectr. 2015. PMID: 26185088
-
Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis.Int J Mol Sci. 2020 Nov 19;21(22):8729. doi: 10.3390/ijms21228729. Int J Mol Sci. 2020. PMID: 33227973 Free PMC article. Review.
-
Gut microbiota influence tumor development and Alter interactions with the human immune system.J Exp Clin Cancer Res. 2021 Jan 25;40(1):42. doi: 10.1186/s13046-021-01845-6. J Exp Clin Cancer Res. 2021. PMID: 33494784 Free PMC article. Review.
-
Gut microbiota shape B cell in health and disease settings.J Leukoc Biol. 2021 Aug;110(2):271-281. doi: 10.1002/JLB.1MR0321-660R. Epub 2021 May 11. J Leukoc Biol. 2021. PMID: 33974295 Review.
Cited by
-
Natto consumption suppresses atherosclerotic plaque progression in LDL receptor-deficient mice transplanted with iRFP-expressing hematopoietic cells.Sci Rep. 2023 Dec 18;13(1):22469. doi: 10.1038/s41598-023-48562-y. Sci Rep. 2023. PMID: 38110459 Free PMC article.
-
Meta-analysis of flavonoids use into beef and dairy cattle diet: Performance, antioxidant status, ruminal fermentation, meat quality, and milk composition.Front Vet Sci. 2023 Feb 15;10:1134925. doi: 10.3389/fvets.2023.1134925. eCollection 2023. Front Vet Sci. 2023. PMID: 36876000 Free PMC article.
-
The first taxonomic and functional characterization of human CAVD-associated microbiota.Microb Cell. 2023 Jan 13;10(2):36-48. doi: 10.15698/mic2023.02.791. eCollection 2023 Feb 6. Microb Cell. 2023. PMID: 36789351 Free PMC article.
-
NEIL3-deficiency increases gut permeability and contributes to a pro-atherogenic metabolic phenotype.Sci Rep. 2021 Oct 5;11(1):19749. doi: 10.1038/s41598-021-98820-0. Sci Rep. 2021. PMID: 34611194 Free PMC article.
-
The Types and Proportions of Commensal Microbiota Have a Predictive Value in Coronary Heart Disease.J Clin Med. 2021 Jul 15;10(14):3120. doi: 10.3390/jcm10143120. J Clin Med. 2021. PMID: 34300286 Free PMC article. Review.
References
-
- Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868–874. - PubMed
-
- Wick G, Knoflach M, Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol. 2004;22:361–403. - PubMed
-
- Fatkhullina AR, Peshkova IO, Dzutsev A, Aghayev T, McCulloch JA, Thovarai V, Badger JH, Vats R, Sundd P, Tang HY et al (2018) An interleukin-23-interleukin-22 axis regulates intestinal microbial homeostasis to protect from diet-induced atherosclerosis. Immunity 49(943–957) e949:943–957.e9 - PMC - PubMed
-
- Jonsson AL, Backhed F. Role of gut microbiota in atherosclerosis. Nat Rev Cardiol. 2017;14:79–87. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical